BioCryst Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| CSL | CSL | Outperform |
12
|
$275.50 | $205.51 | -26.26% | 5 | $133.14B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.50k | ¥5.24k | 5.42% | 0 | ¥10.55T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 10.30% | 0 | ¥6.47T |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$82.10 | $111.56 | 33.98% | 5 | $15.59B |
| 4507 | Shionogi & | Outperform |
18
|
¥7.34k | ¥7.12k | 8.93% | 0 | ¥2.09T |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$42.28 | $55.60 | 41.91% | 3 | $6.12B |
| NTLA | Intellia Therapeutics | Outperform |
8
|
$23.72 | $75.84 | 195.11% | 21 | $2.06B |
| PHARM | Pharming Group N.V. | Buy |
16
|
0.90€ | 1.85€ | 127.78% | 2 | 590.27€M |
| KALV | KalVista Pharmaceuticals | Buy |
7
|
$12.14 | $20.80 | 188.30% | 0 | $478.84M |